Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

Nephrotic Syndrome: early-phase trial registry

6 of 8 indexed Nephrotic Syndrome trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #2,176 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

8 US clinical trials · 6 currently recruiting · #2,176 of 28,707 conditions by registered trial count

Nephrotic Syndrome: 8 US clinical trials tracked, 6 recruiting.

Nephrotic Syndrome is the subject of 8 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 2 of these trials.

Enrollment posture brief

Registry condition nephrotic-syndrome

OPEN 6 | RECR 75% | LATE 1 | EARLY 3 | RANK #2176 | SPON 2

Volume-matched condition peers

Nearest open-share peer: Adolescent Idiopathic Scoliosis (75% recruiting · 8 trials)

Activity, Motor75%Nephrotic Syndrome (this)75%Achalasia50%Abdominal Cancer25%Acne Scars - Mixed Atrophic 25%
Open-enrollment share among volume-matched conditions near Nephrotic Syndrome

Nephrotic Syndrome lists 6 open slots (75% of 8 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Nephrotic Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Nephrotic Syndrome is recruiting above its size-band peers.

    6 of 8 indexed trials (75%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Nephrotic Syndrome research.

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for 2 of 8 trials (25%). 7 distinct sponsors appear on at least one study for this condition label.

  3. Typical Nephrotic Syndrome enrolment sits around 150 participants.

    Median target enrolment is 150 among the 8 trials that report a genuine target (sentinel values excluded). 4 of those (50%) plan for fewer than 100 participants.

  4. Nephrotic Syndrome splits between interventional and observational designs.

    5 interventional and 3 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 23Phase 41

Phase Distribution

PhaseTrial count
Phase 2 3
Phase 4 1

Top Sponsors

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2 trials
Southeast Renal Research Institute 1 trials
Vera Therapeutics 1 trials
National Institute of Allergy and Infectious Diseases (NIAID) 1 trials
Beth Israel Deaconess Medical Center 1 trials
University of Michigan 1 trials
University of Texas Southwestern Medical Center 1 trials

Named interventions

Most-linked intervention names on Nephrotic Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Diuretic Tuner Device
1 trials
Atacicept Drug
1 trials
Oral Cyclosporine Drug
1 trials
Rituximab Infusion Drug
1 trials
ACTH Drug
1 trials
Interview Behavioral
1 trials
Placebo for Belimumab Drug
1 trials
Belimumab Drug
1 trials

US sites by state

Facility locations filed on Nephrotic Syndrome trials. A trial with sites in several states counts in each.

Maryland 3 trials
Michigan 2 trials
California 2 trials
Washington 1 trials
Texas 1 trials
Tennessee 1 trials
Pennsylvania 1 trials
Ohio 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Nephrotic Syndrome page

8 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Nephrotic Syndrome condition card totals 8 registered trials; most-linked intervention Diuretic Tuner; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.